How Is Cancer Diagnosed?

 

If your doctor suspects that you have cancer based on your symptoms or the results of a screening test or clinical examination, he or she will order certain diagnostic tests to find out whether you have abnormal cells and, if so, whether they are malignant (cancerous) or non-malignant (non-cancerous). If the tests show that the cells are malignant, you may need more tests to find out more about the cancer cells.

Many types of tests are used to diagnose cancer:

Biopsies -- A biopsy is usually the only way to tell for sure whether you have cancer or not. The doctor cuts out a small piece of tissue (a groupf of similar cells) and sends it to a laboratory to be studied. A pathologist (a doctor who specializes in diagnosing diseases) looks at the tissue under a microscope to see whether it has cancerous cells.

Imaging tests -- These tests or evaluation procedures produce pictures of areas inside the body. They include x-rays, like mammograms, computed tomography (CT or CAT) scans, and magnetic resonance imaging (MRI) scans. Other common imaging tests include ultrasound and positron emission tomography (PET) scans.

Laboratory tests -- A laboratory technician measures substances in the blood or urine that can indicate how advanced the cancer is or other features of your cancer.

Genomics tests -- Polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), and other genomics tests (tests of genes and their functions) can find mutations (unusual changes) in certain genes that are known to cause cancer.

Latest Cancer News
Late Mortality Persists Beyond Five Years in Children with Cancer

October 6, 2008 — Researchers affiliated with the Children’s Oncology Group have reported that children with cancer who survive five years still remain at risk and need continued observation. The details of this study appeared in an early online publication in the Journal of the National Cancer Institute on September 23, 2008.

Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer

October 6, 2008 — According to the results of a Phase III clinical trial, treatment with Avastin® (bevacizumab) plus Tarceva® (erlotinib) did not result in better survival than treatment with Tarceva alone among patients with advanced non–small cell lung cancer (NSCLC) whose disease had progressed following platinum-based chemotherapy. These results were recently published in a press release by Genentech.

Possible Link between Hepatitis B Virus and Pancreatic Cancer

October 6, 2008 — Researchers from the M. D. Anderson Cancer Center in Texas have reported that exposure to the hepatitis B virus may be associated with the development of pancreatic cancer. The study was recently published in the October 1, 2008 issue of the Journal of Clinical Oncology.

Select news items provided by Reuters Health